| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CBIC.201000792 |
| P698 | PubMed publication ID | 21387510 |
| P50 | author | Norbert Sträter | Q28359656 |
| P2093 | author name string | Ralf Hoffmann | |
| Daniel Knappe | |||
| Guido Schiffer | |||
| Michael Zahn | |||
| Ute Sauer | |||
| P2860 | cites work | Structural analysis of substrate binding by the molecular chaperone DnaK | Q27732810 |
| Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America | Q29616084 | ||
| Rational design of novel peptidic DnaK ligands | Q30318620 | ||
| Resistance patterns among nosocomial pathogens: trends over the past few years | Q31920743 | ||
| The short proline-rich antibacterial peptide family | Q34836522 | ||
| The epidemiology and control of Acinetobacter baumannii in health care facilities | Q36382140 | ||
| Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern | Q37091253 | ||
| Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City | Q39687830 | ||
| Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens. | Q39690252 | ||
| Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. | Q42112359 | ||
| Acinetobacter baumannii infections in a surgical intensive care unit: predictors of multi-drug resistance | Q43452961 | ||
| The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding | Q43547658 | ||
| Sequence-dependent peptide binding orientation by the molecular chaperone DnaK. | Q46452004 | ||
| Role of the Escherichia coli SbmA in the antimicrobial activity of proline-rich peptides. | Q54435427 | ||
| P433 | issue | 6 | |
| P921 | main subject | DNA design | Q55213961 |
| P304 | page(s) | 874-6 | |
| P577 | publication date | 2011-04-11 | |
| P1433 | published in | ChemBioChem | Q634395 |
| P1476 | title | Rational design of oncocin derivatives with superior protease stabilities and antibacterial activities based on the high-resolution structure of the oncocin-DnaK complex | |
| P478 | volume | 12 |
| Q35154887 | Antimicrobial and immunomodulatory activities of PR-39 derived peptides |
| Q50908330 | Controlled systemic release of therapeutic peptides from PEGylated prodrugs by serum proteases. |
| Q48111070 | Correlating uptake and activity of proline-rich antimicrobial peptides in Escherichia coli. |
| Q37277482 | Database-Guided Discovery of Potent Peptides to Combat HIV-1 or Superbugs |
| Q34360125 | Development of second generation peptides modulating cellular adiponectin receptor responses. |
| Q28546662 | DnaK as Antibiotic Target: Hot Spot Residues Analysis for Differential Inhibition of the Bacterial Protein in Comparison with the Human HSP70 |
| Q44220826 | Effect of antimicrobial peptides from Apis mellifera hemolymph and its optimized version Api88 on biological activities of human monocytes and mast cells |
| Q34428190 | His-tag protein monitoring by a fast mix-and-measure immunoassay |
| Q37175214 | Hsp110 is a bona fide chaperone using ATP to unfold stable misfolded polypeptides and reciprocally collaborate with Hsp70 to solubilize protein aggregates. |
| Q38970681 | Immunogenicity and pharmacokinetics of short, proline-rich antimicrobial peptides |
| Q37710376 | In vivo Efficacy and Pharmacokinetics of Optimized Apidaecin Analogs |
| Q41739821 | Insect-derived proline-rich antimicrobial peptides kill bacteria by inhibiting bacterial protein translation at the 70S ribosome |
| Q38855258 | Insect-derived short proline-rich and murine cathelicidin-related antimicrobial peptides act synergistically on Gram-negative bacteria in vitro |
| Q26779247 | Insights into the molecular mechanism of allostery in Hsp70s |
| Q38760670 | Intracellular Targeting Mechanisms by Antimicrobial Peptides |
| Q39304670 | Intracellular toxicity of proline-rich antimicrobial peptides shuttled into mammalian cells by the cell-penetrating peptide penetratin |
| Q92431378 | Neuropilin-1 peptide-like ligands with proline mimetics, tested using the improved chemiluminescence affinity detection method |
| Q36505406 | Novel apidaecin 1b analogs with superior serum stabilities for treatment of infections by gram-negative pathogens |
| Q34262733 | Novel peptide-protein assay for identification of antimicrobial peptides by fluorescence quenching |
| Q41236257 | Oncocin Onc72 is efficacious against antibiotic-susceptible Klebsiella pneumoniae ATCC 43816 in a murine thigh infection model |
| Q54333817 | Oncocin derivative Onc72 is highly active against Escherichia coli in a systemic septicaemia infection mouse model. |
| Q35762892 | Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus |
| Q40809842 | Pharmacokinetics and in vivo efficacy of optimized oncocin derivatives |
| Q91138010 | Proline-Rich Peptides with Improved Antimicrobial Activity against E. coli, K. pneumoniae, and A. baumannii |
| Q36379116 | Proline-rich antimicrobial peptides targeting protein synthesis. |
| Q40913286 | Protein aggregation as an antibiotic design strategy |
| Q39608562 | Ribosomal binding and antibacterial activity of ethylene glycol-bridged apidaecin Api137 and oncocin Onc112 conjugates |
| Q36701111 | Structures of proline-rich peptides bound to the ribosome reveal a common mechanism of protein synthesis inhibition. |
| Q92147348 | Systematic Mutagenesis of Oncocin Reveals Enhanced Activity and Insights into the Mechanisms of Antimicrobial Activity |
| Q27683771 | The Receptor for Advanced Glycation End Products (RAGE) Specifically Recognizes Methylglyoxal-Derived AGEs |
| Q35685002 | The mechanism of inhibition of protein synthesis by the proline-rich peptide oncocin |
| Q27700868 | The proline-rich antimicrobial peptide Onc112 inhibits translation by blocking and destabilizing the initiation complex |
| Q38663372 | The proteome targets of intracellular targeting antimicrobial peptides |
Search more.